Anixa Biosciences, Inc. ANIX

Set alert

Price alert · ANIX

All alert types
2.99 USD -0.13 -4.17%

At close

3.03 +0.04 +1.23%

Pre-market · Nov 3, 7:39 AM ET

Bid
3.00 × 2
Ask
3.01 × 2
2.99 Day range 3.15
2.32 52-week range 5.46
YTD
-4.17%
1 year
-27.78%
Open
3.14
Prev close
3.12
Mkt cap
103.94M
Vol
128.34K
Avg vol
278.15K
EPS
-0.32
P/E
0.00
Div yield
0.00%
More statistics
Low
2.99
High
3.15
Forward P/E
-7.17
Beta
0.85
Short ratio
3.03
Inst. own
17.46%
Dividend
0.00
Ex-div date
Earnings
Jan 21, 2025
50-d avg
3.17
200-d avg
3.04
1y target
8.50

MAX chart

Chart tools
Interval

Signals (75)
NameDateAgo
SMA: BullishJul 1, 20264 months ago
SMA: BearishJan 1, 202610 months ago
SMA: BullishApr 1, 20251 year ago
MACD: Buy SignalApr 1, 20251 year ago
MACD: Sell SignalOct 1, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BullishOct 1, 20233 years ago
SMA: BullishOct 1, 20233 years ago
SMA: BearishApr 1, 20233 years ago
SMA: BearishApr 1, 20233 years ago
SMA: BullishJul 1, 20224 years ago
SMA: BullishJul 1, 20224 years ago
SMA: BearishOct 1, 20215 years ago
SMA: BearishOct 1, 20215 years ago
SMA: BullishJan 1, 20215 years ago
SMA: BullishJan 1, 20215 years ago
SMA: BearishOct 1, 20197 years ago
SMA: BearishApr 1, 20197 years ago
SMA: BullishJan 1, 20197 years ago

Newest 20 of 75.

Analyst view

Consensus: none

Price target (mean) 8.50 +184.3% upside
Target (low)
7.00
Target (mean)
8.50
Target (high)
10.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 2
  • 2 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ANIX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.11-0.11 – -0.11-0.09-22.2%00.0%1
Next quarter-0.11-0.11 – -0.11-0.10-10.0%00.0%1
Current year-0.42-0.42 – -0.42-0.32-31.3%0-100.0%1
Next year-0.46-0.46 – -0.46-0.42-9.5%00.0%1

Upgrades and downgrades

The latest rating changes

ANIX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 19, 2024D. Boral CapitalMaintainedBuyBuy
Nov 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 11, 2024D. Boral CapitalMaintainedBuyBuy
Sep 30, 2024EF HuttonMaintainedBuyBuy
Sep 24, 2024EF HuttonMaintainedBuyBuy
Sep 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 9, 2024EF HuttonMaintainedBuyBuy
Aug 7, 2024EF HuttonInitiated—Buy
Jul 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 10, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 21, 2024HC Wainwright & Co.ReiteratedBuyBuy
Feb 13, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 7, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 18, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 29, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jul 28, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jul 12, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 19, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 23, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 18, 2023HC Wainwright & Co.Reiterated—Buy
Apr 18, 2023Chardan CapitalReiterated—Buy
Mar 23, 2023HC Wainwright & Co.Maintained—Buy
Mar 22, 2023Chardan CapitalMaintained—Buy
Feb 28, 2023HC Wainwright & Co.Reiterated—Buy
Dec 23, 2022Chardan CapitalInitiated—Buy
Apr 12, 2021HC Wainwright & Co.Initiated—Buy
Mar 23, 2020Aegis CapitalInitiated—Buy
Dec 30, 2019B. Riley SecuritiesMaintained—Buy